Scientists at the Jackson Laboratory (JAX) have developed an antibody-based therapy against influenza A virus (IAV), which they suggest could change the way the world fights flu, one of the deadliest ...

New antibody-drug conjugates (ADCs) developed at Institute of Science Tokyo combine a CD4 mimic with neutralizing antibodies ...

An antibody developed by researchers works against a wide range of COVID-19 variants and related coronaviruses, including past, present and potentially future strains. A monoclonal antibody appears ...

A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of ...

If the past four decades have taught us anything about HIV, it's to adjust our expectations—despite enormous progress in controlling the virus, no treatment can yet completely eradicate HIV once it ...

Researchers have developed a new type of flu treatment that could have a dramatic impact on the fight against influenza and potentially, other viruses too. This method involves an antibody cocktail, ...

The first peer-reviewed journal in the field of human gene therapy, providing all-inclusive coverage of the research, methods, and clinical developments that are driving today's explosion of gene ...

PITTSBURGH, Jan. 30, 2025 – A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of Pittsburgh and NIH Vaccine Research Center ...

A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of Pittsburgh and NIH Vaccine Research Center researchers report today in ...

The antibody targets a stable part of the bird flu virus, ensuring that the immune protection can resist new variants and offer long-term protection against the globally spreading airborne infection.